Literature DB >> 16917124

Food-borne botulism in the United Kingdom.

Jim McLauchlin1, K A Grant, C L Little.   

Abstract

Food-borne botulism is a rare but serious disease caused by ingestions of neurotoxin [botulinum neurotoxins (BoNTs)] produced as a result of the growth of the bacterium Clostridium botulinum in foods before consumption. The disease is rare in the United Kingdom, and only 62 cases have been recognized between 1922 and 2005. This report provides a brief review of C. botulinum and food-borne botulism as well as descriptions of the six episodes (33 cases with three deaths) of this disease that occurred in the United Kingdom between 1989 and 2005. The six incidents illustrate the importance of the risk factors of poor processing or storage of commercially prepared foods, improper home preservation of foods and travel to countries where botulism is much more common than in the United Kingdom. Even small outbreaks of food-borne botulism can precipitate a national emergency and inundate public health and acute care provision. This report provides a reminder to public health professions of the occurrence, diagnosis, treatment and control of this rare but serious food-borne disease.

Entities:  

Mesh:

Year:  2006        PMID: 16917124     DOI: 10.1093/pubmed/fdl053

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  9 in total

1.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

2.  Food-borne botulism: still actual topic.

Authors:  Waldemar Brola; Malgorzata Fudala; Szymon Gacek; Pawel Gruenpeter
Journal:  BMJ Case Rep       Date:  2013-02-06

3.  Diplopia as the primary presentation of foodborne botulism.

Authors:  Hamid Khakshoor; Ali Akbar Saber Moghaddam; Amir Hossein Vejdani; Blair K Armstrong; Majid Moshirfar
Journal:  Oman J Ophthalmol       Date:  2012-05

4.  Medical treatment for botulism.

Authors:  Colin H Chalk; Tim J Benstead; Joshua D Pound; Mark R Keezer
Journal:  Cochrane Database Syst Rev       Date:  2019-04-17

5.  Three classes of plasmid (47-63 kb) carry the type B neurotoxin gene cluster of group II Clostridium botulinum.

Authors:  Andrew T Carter; John W Austin; Kelly A Weedmark; Cindi Corbett; Michael W Peck
Journal:  Genome Biol Evol       Date:  2014-08       Impact factor: 3.416

6.  Development of immunodetection system for botulinum neurotoxin serotype E.

Authors:  R Sarita; Sarkaraisamy Ponmariappan; Arti Sharma; Dev Vrat Kamboj; A K Jain
Journal:  Indian J Med Res       Date:  2018-06       Impact factor: 2.375

7.  Diversity of the Genomes and Neurotoxins of Strains of Clostridium botulinum Group I and Clostridium sporogenes Associated with Foodborne, Infant and Wound Botulism.

Authors:  Jason Brunt; Arnoud H M van Vliet; Andrew T Carter; Sandra C Stringer; Corinne Amar; Kathie A Grant; Gauri Godbole; Michael W Peck
Journal:  Toxins (Basel)       Date:  2020-09-11       Impact factor: 4.546

8.  Clinical Predictive Values in Botulism: A 10-year Survey.

Authors:  Sara Saeidi; Bita Dadpour; Lida Jarahi; Anahita A Ghamsari; Mahdi J Nooghabi
Journal:  Indian J Crit Care Med       Date:  2021-04

9.  Pan-Genomic Analysis of Clostridium botulinum Group II (Non-Proteolytic C. botulinum) Associated with Foodborne Botulism and Isolated from the Environment.

Authors:  Jason Brunt; Arnoud H M van Vliet; Sandra C Stringer; Andrew T Carter; Miia Lindström; Michael W Peck
Journal:  Toxins (Basel)       Date:  2020-05-08       Impact factor: 5.075

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.